A new study reveals that cannabidiol (CBD) can significantly reduce neuroinflammation associated with Alzheimers disease. In experiments using an Alzheimers mouse model, researchers found that inhaled CBD lowered the activity of key genes driving inflammation and decreased harmful proinflammatory molecules in the brain.
A new study reveals that cannabidiol (CBD) can significantly reduce neuroinflammation associated with Alzheimers disease. In experiments using an Alzheimers mouse model, researchers found that inhaled CBD lowered the activity of key genes driving inflammation and decreased harmful proinflammatory molecules in the brain.
Share this Article
Recommended